… The treatment volume in locally advanced lung cancer often consists of several spatially
separated targets (tumour(s), nodes) which will exhibit differential motion and shifts [12]. These …

… between cardiac dose and overall survival or cardiac events in patients with lung cancer,
this … cannot be drawn regarding the impact of any dose-volume parameters. Nevertheless, a …

… systemic treatment, most patients with localized lung cancer … The dose of radiation delivered
to tumour is limited by the … uninvolved lung and as a result attempts at escalating dose have …

… The foundation of treatment for locally advanced disease is … with concurrent rather than
sequential treatment (4). Control of … radiation dose used for treatment, as well as changes to dose …

… of treatment and reduced normal tissue doses. An alternative technology to account for
tumour motion is respiratory gating, where the radiotherapy beam is only turned on when the …

… increased proportion of lung cancer patients to be treated curatively. High doses delivered
to critical thoracic organs can result in excess mortality with tolerance doses poorly defined. …

… -small cell lung cancer (NSCLC) is unknown, but higher doses were … dose of radiation to
immune cells (EDRIC) on cancer-specific outcomes in an independent cohort of patients treated …

… 65 treatment centers in the United States, we retrospectively reviewed the records of T1-2
N0 non-small cell lung cancer … biologically effective dose and overall survival. We found that …

… Patients in this cohort had failed or were ineligible to receive standard of care treatment,
they received amivantamab at a dose of 1050 mg if <80 kg or 1400 mg if ≥80 kg weekly for …

… lung cancer and cardiovascular prognostic and treatment factors. For the models, time 0
was the start date of radiotherapy and concluded by the date of first MACE/CTCAE (or death for …